Built for Capital Projects That Can’t Afford to Miss
Agile Advisors was founded to serve one mission: helping life science manufacturers reach operational readiness—on time, within budget, and inspection-ready. Our team brings decades of experience leading pharmaceutical capital projects across sterile manufacturing, biologics, OSD, and clinical GMP environments.
We operate with the same discipline and precision our clients demand of their own operations. Every service we provide is built to reduce risk, strengthen execution, and deliver production-ready outcomes that hold up under regulatory scrutiny.

Who We Serve
We support capital projects
-
Pharmaceutical manufacturers (OSD, sterile, biologics, cell/gene therapy)
-
CDMOs and clinical GMP manufacturing sites
-
QC laboratories and R&D cleanroom environments
​
Our experience spans greenfield builds, aseptic line installations, multi-phase retrofits, and tech transfer-driven upgrades. For facility types and sector breakdowns, see Industries We Support.

How We Work
Our delivery model is grounded in three principles:
​
-
Owner-Side Alignment: We operate as your representative—not the contractor’s. See how in Owner’s Project Manager (OPM).
-
Execution Discipline: We embed senior leadership, drive project cadence, and own results. More in Program & Project Management.
-
Compliance Integration: We ensure decisions support audit readiness, not just construction completion. Learn more in cGMP Compliance & Operational Readiness.
Leadership Team
Agile Advisors is led by seasoned professionals with decades of experience delivering capital projects in regulated pharmaceutical environments. Our leadership team combines engineering depth, regulatory fluency, and owner-side insight to guide complex initiatives from concept through qualification.
Every leader at Agile has managed projects under real pressure—whether delivering on aggressive timelines, resolving high-impact deviations, or leading multi-vendor teams through CQV. Their backgrounds span sterile fill/finish, biologics, OSD, and clinical GMP programs across both emerging CDMOs and top-tier pharmaceutical manufacturers.
Recent engagements include:
-
Leading the qualification and tech transfer of five aseptic filling lines across $300M+ in capital investment
-
Acting as interim program leadership during the recovery of a failing $100M facility expansion under FDA oversight
-
Supporting operational readiness and inspection prep for new product introduction into a $200M clinical-scale site
Our leadership team remains directly involved in every engagement—ensuring technical decisions align with your business, compliance, and operational goals.
What Our Clients Say

Our Clients








Ready to Talk?
We work with decision-makers who need execution certainty, regulatory alignment, and leadership in the field.